Stevens-Johnson syndrome and toxic epidermal necrolysis: 11-year demographic clinical and prognostic characteristics

6Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute, life-Threatening, severe drug reactions. Randomized studies on these diseases are difficult to perform. Aims and Objectives: The purpose of this study was to summarize the demographic and clinical characteristics of patients with SJS and TEN in a tertiary hospital in Turkey. Materials and Methods: We evaluated the records of 33 patients with SJS and TEN who were followed in our clinic or examined between January 2008 and June 2019, retrospectively. Age, sex, time of admission to hospital, causative drug, presence of concomitant disease, skin findings, mucosal involvement, the severity-of-illness score for TEN, the medication used, antibiotic use, transfer to intensive care, development of complications, and death or discharge status were noted. Results: Of the 33 patients, 11 (33.3%) had SJS, 3 (9.1%) had SJS/TEN overlap, and 19 (57.6%) had TEN. The majority (60.6%) of the patients were female. Nineteen (57.6%) patients had one, and 13 (39.4%) had more than one suspected drug exposure in their history. The most commonly suspected drugs were antibiotics. Twelve (36.4%) patients had intensive care unit hospitalization. Ten (30.3%) patients died. Conclusion: The demographic data of our study were consistent with the literature. Similar to the literature, antibiotics were the most common reaction-causing drugs. However, antiepileptic drugs, which were more frequently reported in other studies, were identified as suspicious in only one patient. We believe that our study will contribute to the determination of characteristics of this rare disease with real-life data.

References Powered by Scopus

Scorten: A severity-of-illness score for toxic epidermal necrolysis

941Citations
N/AReaders
Get full text

Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study

865Citations
N/AReaders
Get full text

Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis

247Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

4Citations
N/AReaders
Get full text

Pembrolizumab-induced toxic epidermal necrolysis: A rare cause of severe adverse drug reaction

1Citations
N/AReaders
Get full text

RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Acar, A., Yoldas, A., Turk, B., Karaarslan, I., Sagduyu, I., Ceylan, C., … Ozturk, G. (2022). Stevens-Johnson syndrome and toxic epidermal necrolysis: 11-year demographic clinical and prognostic characteristics. Indian Journal of Dermatology, 67(1), 12–18. https://doi.org/10.4103/ijd.IJD_671_21

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Researcher 1

25%

Readers' Discipline

Tooltip

Engineering 2

40%

Nursing and Health Professions 1

20%

Neuroscience 1

20%

Social Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free